IndraLab

Statements

FK228 decreases the amount of USP11. 3 / 3
| 3
reach
"FK228 could enhance anti-tumour activity by upregulating expression of the tumour suppressor USP11 in GBM cells."
31993801
reach
"FK228 could enhance anti-tumour activity against GBM by upregulating the expression of the tumour suppressor USP11."
31993801
reach
"FK228 could enhance anti-tumour activity by upregulating expression of the tumour suppressor USP11 in GBM cells.Conclusions: EGFR-vIII mutation downregulates H2AZK4/7AC and H3K27AC, inhibiting USP11 expression though the PI3K/AKT-HDAC1/2 axis."
31993801